Results 31 to 40 of about 2,311,673 (316)

Influence of anticardiolipin and anti-β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification [PDF]

, 2019
Background: Anticardiolipin (aCL) and anti-beta 2 glycoprotein I (a beta 2GPI) immunoglobulin (Ig) G/IgM antibodies are 2 of the 3 laboratory criteria for classification of antiphospholipid syndrome (APS).
de Laat, Bas, Devreese, Katrien, Kelchtermans, Hilde, Musial, Jacek, Vanoverschelde, Laura   +4 more
core   +3 more sources

Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection

Journal of Investigative Medicine High Impact Case Reports, 2023
COVID-19 infection has been found to precipitate hypercoagulability and transiently increase antiphospholipid antibodies. However, it is yet to be determined how likely these transient changes contribute to thrombotic events and antiphospholipid syndrome.
Lauren Bitterman MD, Mahdis Solhjoo MD, Vivek Shah MD, Sue Min Kwon MD, Karina Torralba MD, Hana Kazbour MD   +5 more
doaj   +1 more source

Audio-vestibular symptoms in systemic autoimmune diseases [PDF]

, 2018
Immune-mediated inner ear disease can be primary, when the autoimmune response is against the inner ear, or secondary. The latter is characterized by the involvement of the ear in the presence of systemic autoimmune conditions. Sensorineural hearing loss
Adelchi, Croce, D'AGUANNO, VITTORIO, DE VINCENTIIS, Marco, DE VIRGILIO, ARMANDO, DI STADIO, Arianna, GRECO, Antonio, LONGO, Lucia, RALLI, MASSIMO   +7 more
core   +1 more source

EULAR recommendations for the management of antiphospholipid syndrome in adults

Annals of the Rheumatic Diseases, 2019
The objective was to develop evidence-based recommendations for the management of antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature review and expert opinion, overarching principles and recommendations were ...
Maria G. Tektonidou, L. Andreoli, M. Limper, Z. Amoura, R. Cervera, N. Costedoat-Chalumeau, M. Cuadrado, T. Dörner, Raquel Ferrer-Oliveras, K. Hambly, M. Khamashta, J. King, F. Marchiori, P. Meroni, M. Mosca, V. Pengo, L. Raio, G. Ruiz‐Irastorza, Y. Shoenfeld, L. Stojanovich, E. Svenungsson, D. Wahl, A. Tincani, M. Ward   +23 more
semanticscholar   +1 more source

Renal Involvement in Antiphospholipid Syndrome

Frontiers in Immunology, 2018
Antiphospholipid syndrome is a complex autoimmune disease, characterized by the presence of vascular thrombosis, obstetric, hematologic, cutaneous, and cardiac manifestations. Renal disease in patients with antiphospholipid syndrome was not recognized in
Alonso Turrent-Carriles, Juan Pablo Herrera-Félix, Mary-Carmen Amigo   +2 more
doaj   +1 more source

Loss of maternal annexin A5 increases the likelihood of placental platelet thrombosis and foetal loss [PDF]

, 2012
Antiphospholipid syndrome is associated with an increased risk of thrombosis and pregnancy loss. Annexin A5 (Anxa5) is a candidate autoantigen. It is not known, however, whether endogenous Anxa5 prevents foetal loss during normal pregnancy.
Brachvogel, Bent, Hasegawa, Yoshihisa, Kawaminami, Mitsumori, Kurusu, Shiro, Laoharatchatathanin, Titaree, Mizushina, Tomona, Nishimura, Yasuhiro, Poschl, Ernst, Rieanrakwong, Duangjai, Terashima, Ryota, Ueki, Hiroshi, Yonezawa, Tomohiro   +11 more
core   +1 more source

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management

Haematologica, 2020
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by arterial and venous thrombotic manifestations and/or pregnancy-related complications in patients with persistently high antiphospholipid antibodies (aPL), the most common ...
P. Pignatelli, E. Ettorre, D. Menichelli, A. Pani, F. Violi, D. Pastori   +5 more
semanticscholar   +1 more source

Cardiac arrest in the setting of probable catastrophic antiphospholipid syndrome in young patient with a history of COVID infection and polyglandular disorder—Case report

SAGE Open Medical Case Reports, 2023
Antiphospholipid syndrome is an autoimmune disorder characterized by arterial and venous thrombosis and recurrent spontaneous abortions due to the persistent presence of antiphospholipid antibodies.
Seyed M Nahidi, Yash Garg, Devi S Mahadeo, Manjari Sharma, Cesar Acosta, Karthik Seetharam, Mukosolu F Obi   +6 more
doaj   +1 more source

Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis, 2020
Clarity and guidance is required with regard to the use of direct oral anticoagulants in antiphospholipid syndrome (APS) patients, within the confines of the recent European Medicines Agency recommendations, discrepant recommendations in other ...
S. Zuily, H. Cohen, D. Isenberg, S. Woller, M. Crowther, V. Dufrost, D. Wahl, C. Doré, A. Cuker, M. Carrier, V. Pengo, K. Devreese   +11 more
semanticscholar   +1 more source

Implications of Antiphospholipid and Antineutrophilic Cytoplasmic Antibodies in the Context of Postinfectious Glomerulonephritis. [PDF]

, 2017
While antineutrophil cytoplasmic antibody (ANCA) positivity has been documented in some patients with postinfectious glomerulonephritis (PIGN) and is associated with more severe disease, antiphospholipid antibodies (APA) are not known to be a common ...
Butani, Lavjay, Leifer, Daniel
core   +4 more sources